with the deaths of eight people with underlying health conditions.
Health officials in South Korea said there was no evidence that proved that the Oxford/AstraZeneca shot played a role in the deaths of the patients who had "adverse reactions" to the jab.
It comes after an investigation was launched into their deaths last week.
At the end of February, South Korean officials started to rollout their Covid vaccine programme - jabbing residents and workers at nursing homes and other at-risk individuals.
However, at the start of the rollout in South Korea, people aged over 65 were not being given the jab after health regulators in the country stated that more data on efficacy was needed on the age group.
Today the Korea Disease Control and Prevention Agency (KDCA) said a panel had recommended that the jab could be given to those in older age groups.
It also confirmed that the Oxford jab had not played a role in the deaths.
In a statement the regulator said: "We’ve tentatively concluded that it was difficult to establish any link between their adverse reaction after being vaccinated, and their deaths."